{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05308654",
            "orgStudyIdInfo": {
                "id": "M21-406"
            },
            "secondaryIdInfos": [
                {
                    "id": "2022-501685-22-01",
                    "type": "OTHER",
                    "domain": "EU CT"
                }
            ],
            "organization": {
                "fullName": "AbbVie",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets",
            "officialTitle": "First-in-Human Study of the BCL-2 Inhibitor ABBV-453 in Biomarker-Selected Subjects With Relapsed or Refractory Multiple Myeloma",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-assess-the-adverse-events-and-change-in-disease-activity-in-adult-participants-with-relapsed-or-refractory-multiple-myeloma-receiving-oral-abbv-tablets"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-05-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-08-28",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-08-28",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-03-25",
            "studyFirstSubmitQcDate": "2022-03-25",
            "studyFirstPostDateStruct": {
                "date": "2022-04-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "AbbVie",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "Multiple myeloma (MM) is a plasma cell disease characterized by the growth of clonal plasma cells in the bone marrow. The purpose of this study is to assess the safety and toxicity of ABBV-453 in adult participants with relapsed/refractory (R/R) MM. Adverse events and change in disease activity will be assessed.\n\nABBV-453 is an investigational drug being developed for the treatment of R/R MM. Part 1 will be a monotherapy dose escalation phase to determine the best dose of ABBV-453. In Part 2, participants are placed in 1 of 3 groups called treatment arms. Each group receives a different treatment. Approximately 28 to 48 adult participants in Part 1 and 150 to 312 adult participants in Part 2 with R/R MM will be enrolled in the study in approximately 70 sites worldwide.\n\nIn Part 1 and the Japan Cohort, Participants will receive oral ABBV-453 tablets once daily (QD) in 28-day cycles. In Part 2, Arm 1, participants will receive continuous doses of oral ABBV-453 tablets QD in combination with oral dexamethasone tablets once weekly in 28-day cycles. In Part 2, Arm 2, participants will receive continuous doses of oral ABBV-453 tablets QD in combination with subcutaneous injections of daratumumab every 1 to 4 weeks and oral dexamethasone tablets once weekly in, 28-day cycles. In Part 2, Arm 3, participants will receive continuous doses of oral ABBV-453 tablets QD in combination with subcutaneous injections of daratumumab every 1 to 4 weeks, oral lenalidomide capsules QD on Days 1-21, and oral dexamethasone tablets once weekly, in 28-day cycles.\n\nThere may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at an approved institution (hospital or clinic). The effect of the treatment will be frequently checked by medical assessments, blood tests, and side effects."
        },
        "conditionsModule": {
            "conditions": [
                "Relapsed/Refractory Multiple Myeloma"
            ],
            "keywords": [
                "Relapsed/Refractory Multiple Myeloma",
                "ABBV-453",
                "Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 360,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Part 1: Monotherapy Dose Escalation",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with relapsed or refractory (R/R) multiple myeloma (MM) will receive escalating doses of ABBV-453, until the maximum tolerated dose (MTD) is determined.",
                    "interventionNames": [
                        "Drug: ABBV-453"
                    ]
                },
                {
                    "label": "Part 2: Arm 1",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive continuous doses of ABBV-453 in combination with dexamethasone in 28-day cycles.",
                    "interventionNames": [
                        "Drug: ABBV-453",
                        "Drug: Dexamethasone"
                    ]
                },
                {
                    "label": "Part 2: Arm 2",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive continuous doses of ABBV-453 in combination with daratumumab and dexamethasone in 28-day cycles.",
                    "interventionNames": [
                        "Drug: ABBV-453",
                        "Drug: Dexamethasone",
                        "Drug: Daratumumab"
                    ]
                },
                {
                    "label": "Part 2: Arm 3",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive continuous doses of ABBV-453 in combination with daratumumab, lenalidomide, and dexamethasone in 28-day cycles.",
                    "interventionNames": [
                        "Drug: ABBV-453",
                        "Drug: Dexamethasone",
                        "Drug: Daratumumab",
                        "Drug: Lenalidomide"
                    ]
                },
                {
                    "label": "Japan Cohort",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with R/R MM will receive escalating doses of ABBV-453, until the MTD is determined.",
                    "interventionNames": [
                        "Drug: ABBV-453"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "ABBV-453",
                    "description": "Oral; Tablet",
                    "armGroupLabels": [
                        "Japan Cohort",
                        "Part 1: Monotherapy Dose Escalation",
                        "Part 2: Arm 1",
                        "Part 2: Arm 2",
                        "Part 2: Arm 3"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Dexamethasone",
                    "description": "Oral Tablet",
                    "armGroupLabels": [
                        "Part 2: Arm 1",
                        "Part 2: Arm 2",
                        "Part 2: Arm 3"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Daratumumab",
                    "description": "Subcutaneous Injection",
                    "armGroupLabels": [
                        "Part 2: Arm 2",
                        "Part 2: Arm 3"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Lenalidomide",
                    "description": "Oral Capsule",
                    "armGroupLabels": [
                        "Part 2: Arm 3"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Overall Response Rate (ORR) per International Myeloma Working Group (IMWG) Criteria",
                    "description": "ORR is defined as the percentage of participants with a confirmed best overall response (BOR) of partial response (PR) + very good partial response (VGPR) + complete response (CR) + stringent complete response (sCR) as assessed by investigators per adapted IMWG criteria for relapsed or refractory (R/R) multiple myeloma (MM).",
                    "timeFrame": "Up to Approximately 12 Months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Duration of Response (DOR)",
                    "description": "DOR is defined for participants achieving a confirmed sCR/CR/VGPR/PR as the time from the initial response of sCR/CR/VGPR/PR per investigator review according to adapted IMWG criteria to disease progression or death of any cause, whichever occurs earlier.",
                    "timeFrame": "Up to Approximately 24 Months"
                },
                {
                    "measure": "Depth of Response Minimal Residual Disease (MRD)",
                    "description": "MRD negativity is defined as having less than 1 myeloma cell that may remain in the bone marrow aspirate. Depth of response is defined as the proportion of MRD negativity for participants achieving a confirmed sCR/CR per investigator review according to IMWG criteria.",
                    "timeFrame": "Up to Approximately 24 Months"
                },
                {
                    "measure": "Progression Free Survival (PFS)",
                    "description": "PFS is defined as time from first study treatment to a documented disease progression according to adapted IMWG criteria, as determined by the investigator, or death due to any cause, whichever occurs earlier.",
                    "timeFrame": "Up to Approximately 36 Months"
                },
                {
                    "measure": "Overall Survival (OS)",
                    "description": "Overall survival (OS) is defined as time from first study treatment to death due to any cause.",
                    "timeFrame": "Up to Approximately 36 Months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Eastern Cooperative Oncology Group (ECOG) performance status \\<= 1.\n* Laboratory values meeting the criteria outlined in the protocol.\n* Documented diagnosis of multiple myeloma (MM) based on standard International Myeloma Working Group (IMWG) criteria.\n* Has measurable disease at screening as defined in the protocol.\n* Locally documented or centrally determined t(11;14) positive status and/or centrally determined BCL2high status. Note: If local testing for t(11;14) is discordant with central testing for t(11;14) status, a detailed review of central and local results for t(11;14) status is required to ensure the participants' safety.\n* Part 1 and Part 2, Arm 1 Only: Refractory to or intolerant of all established MM therapies that are known to provide clinical benefit and are triple class exposed to a proteasome inhibitors (PI), an Immunomodulatory drugs (IMID), and an anti-CD38 monoclonal antibody in previous line(s) of therapy.\n* Part 2, Arms 2 and 3 Only: Received 1 to 3 prior lines of therapy, including a PI or an IMiD.\n* Part 1 only: Permitted to be venetoclax or BCL-2 inhibitor exposed in previous lines of therapy.\n* Life expectancy \\>= 12 weeks.\n\nExclusion Criteria:\n\n* Clinically relevant or significant Electrocardiogram (ECG) abnormalities as outlined in the protocol.\n* Part 2 only: Previous treatment with venetoclax or BCL-2 inhibitor.\n* Part 2, Arms 2 and 3 only: Prior daratumumab or other anti-CD38 therapy exposure that meets any of the criteria outlined in the protocol.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "ABBVIE CALL CENTER",
                    "role": "CONTACT",
                    "phone": "844-663-3742",
                    "email": "abbvieclinicaltrials@abbvie.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "ABBVIE INC.",
                    "affiliation": "AbbVie",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Stanford University School of Med /ID# 242809",
                    "status": "RECRUITING",
                    "city": "Stanford",
                    "state": "California",
                    "zip": "94305-2200",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.42411,
                        "lon": -122.16608
                    }
                },
                {
                    "facility": "Sylvester Comprehensive Cancer Center /ID# 243417",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136-1002",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Tulane University /ID# 244854",
                    "status": "RECRUITING",
                    "city": "New Orleans",
                    "state": "Louisiana",
                    "zip": "70112-2699",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.95465,
                        "lon": -90.07507
                    }
                },
                {
                    "facility": "American Oncology Partners of Maryland, PA /ID# 244858",
                    "status": "RECRUITING",
                    "city": "Bethesda",
                    "state": "Maryland",
                    "zip": "20817",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.98067,
                        "lon": -77.10026
                    }
                },
                {
                    "facility": "University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 242754",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "Mayo Clinic - Rochester /ID# 242844",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905-0001",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center /ID# 243503",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065-6007",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Univ NC Chapel Hill /ID# 243420",
                    "status": "RECRUITING",
                    "city": "Chapel Hill",
                    "state": "North Carolina",
                    "zip": "27514-4220",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.9132,
                        "lon": -79.05584
                    }
                },
                {
                    "facility": "Duke Univ Med Ctr /ID# 242808",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "Wake Forest Baptist Health /ID# 244252",
                    "status": "RECRUITING",
                    "city": "Winston-Salem",
                    "state": "North Carolina",
                    "zip": "27157-0001",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.09986,
                        "lon": -80.24422
                    }
                },
                {
                    "facility": "Penn Presbyterian Medical Center /ID# 242842",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104-2640",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Vanderbilt Ingram Cancer Center /ID# 242810",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37232-0021",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "Liverpool Hospital /ID# 244826",
                    "status": "RECRUITING",
                    "city": "Liverpool",
                    "state": "New South Wales",
                    "zip": "2170",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -33.90011,
                        "lon": 150.93328
                    }
                },
                {
                    "facility": "St Vincent's Hospital Melbourne /ID# 244827",
                    "status": "RECRUITING",
                    "city": "Fitzroy Melbourne",
                    "state": "Victoria",
                    "zip": "3065",
                    "country": "Australia"
                },
                {
                    "facility": "St. Vincent's Private Hospital Melbourne /ID# 262631",
                    "status": "RECRUITING",
                    "city": "Fitzroy",
                    "state": "Victoria",
                    "zip": "3065",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.79839,
                        "lon": 144.97833
                    }
                },
                {
                    "facility": "Austin Health and Ludwig Institute for Cancer Research /ID# 248311",
                    "status": "RECRUITING",
                    "city": "Heidelberg",
                    "state": "Victoria",
                    "zip": "3084",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.75,
                        "lon": 145.06667
                    }
                },
                {
                    "facility": "Epworth Healthcare /ID# 248705",
                    "status": "RECRUITING",
                    "city": "Richmond",
                    "state": "Victoria",
                    "zip": "3121",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.81819,
                        "lon": 145.00176
                    }
                },
                {
                    "facility": "The Chaim Sheba Medical Center /ID# 250482",
                    "status": "RECRUITING",
                    "city": "Ramat Gan",
                    "state": "Tel-Aviv",
                    "zip": "5265601",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.08227,
                        "lon": 34.81065
                    }
                },
                {
                    "facility": "Tel Aviv Sourasky Medical Center /ID# 250483",
                    "status": "RECRUITING",
                    "city": "Tel Aviv",
                    "state": "Tel-Aviv",
                    "zip": "6423906",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.08088,
                        "lon": 34.78057
                    }
                },
                {
                    "facility": "Hadassah Medical Center-Hebrew University /ID# 250484",
                    "status": "RECRUITING",
                    "city": "Jerusalem",
                    "state": "Yerushalayim",
                    "zip": "91120",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 31.76904,
                        "lon": 35.21633
                    }
                },
                {
                    "facility": "Barts Health NHS Trust /ID# 248972",
                    "status": "RECRUITING",
                    "city": "London",
                    "state": "London, City Of",
                    "zip": "E1 2ES",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "removedCountries": [
                "Canada",
                "France",
                "Germany",
                "Spain",
                "Sweden"
            ]
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009101",
                    "term": "Multiple Myeloma"
                },
                {
                    "id": "D000054219",
                    "term": "Neoplasms, Plasma Cell"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000020141",
                    "term": "Hemostatic Disorders"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000010265",
                    "term": "Paraproteinemias"
                },
                {
                    "id": "D000001796",
                    "term": "Blood Protein Disorders"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000006474",
                    "term": "Hemorrhagic Disorders"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12058",
                    "name": "Multiple Myeloma",
                    "asFound": "Multiple Myeloma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M27588",
                    "name": "Neoplasms, Plasma Cell",
                    "asFound": "Multiple Myeloma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M21977",
                    "name": "Hemostatic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5059",
                    "name": "Blood Coagulation Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M13178",
                    "name": "Paraproteinemias",
                    "relevance": "LOW"
                },
                {
                    "id": "M5077",
                    "name": "Blood Protein Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9560",
                    "name": "Hemorrhagic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3947",
                    "name": "Multiple Myeloma",
                    "asFound": "Multiple Myeloma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003907",
                    "term": "Dexamethasone"
                },
                {
                    "id": "D000077269",
                    "term": "Lenalidomide"
                },
                {
                    "id": "C000556306",
                    "term": "Daratumumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000000932",
                    "term": "Antiemetics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000005938",
                    "term": "Glucocorticoids"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000018931",
                    "term": "Antineoplastic Agents, Hormonal"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000020533",
                    "term": "Angiogenesis Inhibitors"
                },
                {
                    "id": "D000043924",
                    "term": "Angiogenesis Modulating Agents"
                },
                {
                    "id": "D000006133",
                    "term": "Growth Substances"
                },
                {
                    "id": "D000006131",
                    "term": "Growth Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7102",
                    "name": "Dexamethasone",
                    "asFound": "High",
                    "relevance": "HIGH"
                },
                {
                    "id": "M235549",
                    "name": "Dexamethasone acetate",
                    "relevance": "LOW"
                },
                {
                    "id": "M1725",
                    "name": "Lenalidomide",
                    "asFound": "Respiratory",
                    "relevance": "HIGH"
                },
                {
                    "id": "M272211",
                    "name": "Daratumumab",
                    "asFound": "Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4251",
                    "name": "Antiemetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9047",
                    "name": "Glucocorticoids",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20966",
                    "name": "Antineoplastic Agents, Hormonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M22318",
                    "name": "Angiogenesis Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M9231",
                    "name": "Growth Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "AnEm",
                    "name": "Antiemetics"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}